Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
8 May 2023 |
Main ID: |
ISRCTN67852437 |
Date of registration:
|
18/03/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
BabyGel Pilot: the provision of alcohol handgel to postpartum mothers in Mbale, Eastern Uganda to prevent neonatal infective morbidity in the home.
|
Scientific title:
|
BabyGel Pilot: a pilot study of a cluster randomised trial of the provision of alcohol handgel to postpartum mothers in Mbale, Eastern Uganda to prevent neonatal infective morbidity in the home. |
Date of first enrolment:
|
01/04/2015 |
Target sample size:
|
100 |
Recruitment status: |
Completed |
URL:
|
https://www.isrctn.com/ISRCTN67852437 |
Study type:
|
Observational |
Study design:
|
An open, 2-arm cluster randomised trial with rural villages as the unit of randomisation in Eastern Uganda. (Prevention)
|
Phase:
|
Not Applicable
|
|
Countries of recruitment
|
Uganda
|
Uruguay
| | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Andrew
Weeks |
Address:
|
Sanyu Research Unit
Department of Women's and Children's Health
University of Liverpool
1st Floor
Liverpool Women's Hospital
Crown Street
L8 7SS
Liverpool
United Kingdom |
Telephone:
|
01517959578 |
Email:
|
aweeks@liv.ac.uk |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Women with an estimated gestation of over 34 weeks 2. Reside in the participating villages.
The gestation age will be determined by the Last Normal Menstruation period (LNMP), and or Ultra sound scan.
Exclusion criteria: Women will be excluded from the study if they 1. Are temporary resident (visitors) in one of the Mbale villages 2. Plan to relocate to distant places (outside of the Mbale District) within 3 months of childbirth
Age minimum:
Age maximum:
Gender:
Female
|
Health Condition(s) or Problem(s) studied
|
Reduction in infant (>3 months) sepsis thereby leading to a possible reduction in infant morbidity and mortality Infections and Infestations
|
Intervention(s)
|
A pilot study of a cluster randomised trial of the provision of alcohol handgel to postpartum mothers to prevent neonatal infective morbidity in the home. This pilot study (work stream 1) will be used to formally pilot the planned main open, 2-arm cluster randomised controlled trial (RCT) comparing alcohol hand rub with normal care. This pilot is one of 3 studies being conducted in preparation for the main BabyGel cluster RCT, and will take place in 10 villages around Mbale, Uganda. Workstream 1 will assess the feasibility of conducting the main trial. Other workstreams are evaluating the optimal hand rub formulation (workstream 2) and consent procedures (workstream 3).
The study will be a 3-way, blinded, randomised cross-over study. Forty postnatal women with children aged under 3 months of age will be recruited through the infant vaccination clinics in two local health centres. The only exclusion will be of those who currently use antiseptic hand wash at home and wish to continue its use. The study will be explained to the women at the clinic and they will be given or read a participant information sheet, which will be translated into the local languages. Those who wish to participate will be asked to provide signed consent.
Participants will be randomly allocated to receive one of 3 different alcohol handrubs in a predetermined order. Each participant will use the allocated handrub for 5 consecutive days followed by a 2-day ‘washout’ period in which they will not use any handrub. At the end of each week they will be asked to return to the health centre to complete evaluation forms and to receive the next pack of handrub. Those who do not attend the follow-up will be contacted by telephone and alternative way of follow-up with the research staff arranged (on an alt
|
Primary Outcome(s)
|
1. Infant sepsis (using the Young Infant Clinical Signs Study Group (YICSSG) criteria 2. Sepsis death in the first 90 days of life (assessed using verbal autopsy)
|
Secondary Outcome(s)
|
Neonatal: Physician diagnosed infant infection, Microbiologically confirmed infant infection rate in the first 90 days of life (blood culture and cerebrospinal fluid), Infant mortality at 24hrs, 7 days, 4 weeks, and 3 months of life, Individual infant infections, General: fever, clinical jaundice, Infant weight and height at 3 months Maternal: Gel Hand hygiene compliance, frequency of other hand washing; Maternal postnatal pelvic infection, other infections and satisfaction.
|
Source(s) of Monetary Support
|
Medical Research Council
|
Ethics review
|
Status:
Approval date:
Contact:
1. University of Liverpool Ethics Committee
2. Mbale Regional Hospital Institutional Review Committee (MRHIRC)
|
Results
|
Results available:
|
Yes |
Date Posted:
|
|
Date Completed:
|
28/02/2016 |
URL:
|
|
|
|